|
| Exchange Disseminated Time | Ind-Swift Ltd has informed BSE regarding "Ind-Swift in Collaboration with Wockhardt UK Limited Launches Atorvastatin Tablets in UK".
Announcement:
"Ind-Swift added another feather in its cap by launching generic formulations of the World's best selling drug Atorvastatin in UK in collaboration with Wockhardt UK Ltd. on the first day of its patent expiry. Atorvastatin, is the World's best selling drug with World Market size of US$ 16 billion. The drug went off patent in Europe on May 06, 2012 and taking this opportunity Ind Swift Limited and its EU marketing partner Wockhardt UK Limited launched the generic version of the molecule in UK on day 1 after the patent expiry." (For more details kindly refer Corporate Announcements on www.bseindia.com). |
|
|